-+ 0.00%
-+ 0.00%
-+ 0.00%

KLOTHO NEUROSCIENCES, INC. GRANTED FDA ORPHAN DRUG DESIGNATION FOR KLTO-202 FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS ("ALS" OR "LOU GEHRIG'S DISEASE")

Reuters·07/10/2025 09:00:06

Please log in to view news